United Pharm, Up 7.66% on Rising Theme of COVID-19 (Diagnosis/Treatment/Vaccine Development)
On the 19th, the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme rose by 4.20% compared to the previous day, showing strength, while United Pharm, gaining attention as a related stock, surged by 7.66% compared to the previous day. United Pharm is known as a pharmaceutical manufacturing and sales company.
[Graph] Major stock price changes in the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme
According to the analysis by Thinkpool Robo Algorithm RASSI, United Pharm ranked first in the quant financial ranking (out of a total of 56 stocks) by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as United Pharm having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.
[Table] Top stocks by financial score within the theme
※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
